Core A is organized to meet demonstrated statistical needs of participating scientists in the areas of biostatistical design and analysis, and data management. Please see the Appendix for additional descriptions of biostatistical methodology. The objectives of Core A are as follows: 1. To assist in the biostatistical design of clinical and laboratory studies in this Program Project Grant (PPG). 2. To assist in the analysis of research data. In this role, the core provides assistance to multiple investigators in implementing study protocol design, data entry, data monitoring and analysis and manuscript w r i t i n g . 3. To provide experienced staff to carry out analyses. 4. To assist investigators in all aspects of data management including the organization of their data flow and in the choice and setup of data base management systems. 5. To develop biostatistical methodology for statistical problems arising in this PPG. 6: To provide scientific input more generally as a member of the Executive Committee.

Public Health Relevance

Core A will support all three projects and work closely with other Cores, especially with respect to analyzing data from the trial in combination with the archival patient material. To develop further support for Projects I, II and III we have been pursuing various statistical methodologies for the handling of incomplete data.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA029605-32
Application #
8544991
Study Section
Special Emphasis Panel (ZCA1-RPRB-J)
Project Start
Project End
Budget Start
2013-09-01
Budget End
2014-08-31
Support Year
32
Fiscal Year
2013
Total Cost
$616,448
Indirect Cost
$428,341
Name
John Wayne Cancer Institute
Department
Type
DUNS #
556074458
City
Santa Monica
State
CA
Country
United States
Zip Code
90404
Ozao-Choy, Junko; Lee, Delphine J; Faries, Mark B (2014) Melanoma vaccines: mixed past, promising future. Surg Clin North Am 94:1017-30, viii
Chiu, Connie G; Nakamura, Yoshitaka; Chong, Kelly K et al. (2014) Genome-wide characterization of circulating tumor cells identifies novel prognostic genomic alterations in systemic melanoma metastasis. Clin Chem 60:873-85
Marzese, Diego M; Scolyer, Richard A; Roqué, Maria et al. (2014) DNA methylation and gene deletion analysis of brain metastases in melanoma patients identifies mutually exclusive molecular alterations. Neuro Oncol 16:1499-509
Greenberg, Edward S; Chong, Kelly K; Huynh, Kelly T et al. (2014) Epigenetic biomarkers in skin cancer. Cancer Lett 342:170-7
Tanaka, Ryo; Donovan, Nicholas C; Yu, Qiang et al. (2014) Tumor necrosis factor-* and apoptosis induction in melanoma cells through histone modification by 3-deazaneplanocin A. J Invest Dermatol 134:1470-2
Yang, James C; Sherry, Richard M (2014) MSLT-I-response of clinical trial investigators. Nat Rev Clin Oncol 11:
Nelson, Michael D; Rader, Florian; Tang, Xiu et al. (2014) PDE5 inhibition alleviates functional muscle ischemia in boys with Duchenne muscular dystrophy. Neurology 82:2085-91
Marzese, Diego M; Scolyer, Richard A; Huynh, Jamie L et al. (2014) Epigenome-wide DNA methylation landscape of melanoma progression to brain metastasis reveals aberrations on homeobox D cluster associated with prognosis. Hum Mol Genet 23:226-38
Morton, Donald L; Thompson, John F; Cochran, Alistair J et al. (2014) Final trial report of sentinel-node biopsy versus nodal observation in melanoma. N Engl J Med 370:599-609
Marzese, Diego M; Hirose, Hajime; Hoon, Dave S B (2013) Diagnostic and prognostic value of circulating tumor-related DNA in cancer patients. Expert Rev Mol Diagn 13:827-44

Showing the most recent 10 out of 232 publications